BAP1 and neoplasm: Yavuzyigitoglu et al. reported UM patients harboring an SF3B1 mutation were diagnosed younger at 54.5 years than patients harboring an EIF1AX or BAP1 mutated tumor, diagnosed at 64 years [21].